Stockscreener 앱 받기
10.36
0.39%
0.006
전일 마감가:
$10.35
열려 있는:
$10.41
하루 거래량:
22,247
Relative Volume:
0.06
시가총액:
$428.01M
수익:
$57.80M
순이익/손실:
$-35.29M
주가수익비율:
-10.37
EPS:
-0.9987
순현금흐름:
$-8.42M
1주 성능:
+3.80%
1개월 성능:
+41.36%
6개월 성능:
+55.77%
1년 성능:
+72.59%
1일 변동 폭
$10.35
$10.44
1주일 범위
$9.73
$10.70
52주 변동 폭
$5.025
$10.70
908 디바이시스 Stock (MASS) Company Profile
명칭
908 Devices Inc
전화
978-729-4478
주소
44 THIRD AVENUE, BURLINGTON
Compare MASS vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MASS
908 Devices Inc
|
10.36 | 423.26M | 57.80M | -35.29M | -8.42M | -0.9987 |
ABT
Abbott Laboratories
|
114.75 | 198.01B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
330.92 | 130.41B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
92.36 | 120.48B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
49.62 | 75.37B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
89.54 | 53.19B | 6.30B | 1.07B | 1.09B | 1.8406 |
908 디바이시스 Stock (MASS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-05 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2024-11-13 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2023-02-07 | 개시 | Stephens | Overweight |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-01-12 | 개시 | Cowen | Outperform |
| 2021-01-12 | 개시 | SVB Leerink | Outperform |
| 2021-01-12 | 개시 | Stifel | Buy |
| 2021-01-12 | 개시 | William Blair | Outperform |
모두보기
908 디바이시스 주식(MASS)의 최신 뉴스
908 Devices (MASS) Q2 2026 Earnings Call Transcript - AOL.com
908 Devices (NASDAQ:MASS) Qualifies for Minervini Trend Template and High-Growth Momentum Screen - ChartMill
TG Therapeutics Conference: 908 Devices Bets on Handheld Drug, Chemical Detection - TradingView
908 Devices (MASS) Rises 1.80% as Shares Approach Key Resistance at $10.70Hidden Order - Vinanet
908 Devices CEO Knopp sells $283,677 in common stock - Investing.com
908 Devices CEO Knopp sells $283,677 in common stock By Investing.com - Investing.com India
908 Devices (MASS) CEO offloads 27K shares under preset 10b5-1 plan - Stock Titan
MASS Q2 2026 Earnings: Narrowed Loss Beats Estimates by 36.6%, Shares Tick HigherAnalyst Earnings Estimate - Vinanet
908 Devices (NASDAQ: MASS) founder lines up new stock sale - Stock Titan
908 devices director Christopher Brown sells $169,800 in shares By Investing.com - Investing.com Canada
908 devices director Christopher Brown sells $169,800 in shares - Investing.com
Dimensional Fund Advisors LP Has $726,000 Stake in 908 Devices Inc. $MASS - MarketBeat
908 Devices (MASS) Slips to $10.01, Testing Support Amid Sideways DriftBPI Bull Correction - Vinanet
MASS|908 Devices Inc.|Price:10.010|Chg%:-0.100 - TradingKey
908 Devices Inc. (MASS) Stock News Today - TradingKey
908 Devices Eyes Growth in Handheld Drug and Chemical Detection Market - MarketBeat
908 Devices Stock Price Forecast. Should You Buy MASS? - StockInvest.us
ARCH funds disclose 13.9% ownership of 908 Devices Inc. (MASS) in latest 13G/A - Stock Titan
ARK Investment Management (MASS) reports 2.0M-share, 5.32% holding in 908 Devices - Stock Titan
AWM Investment Company reports 11.8% 908 Devices (MASS) ownership through Special Situations funds - Stock Titan
908 Devices Q2: Another Solid Report (NASDAQ:MASS) - Seeking Alpha
908 Devices (MASS) Stock Price Stalls As Handheld Growth Meets Loss Concerns - Sahm
908 Devices Inc (MASS) (Q2 2026) Earnings Call Highlights: Stron - GuruFocus
908 Devices Inc (MASS) (Q2 2026) Earnings Call Highlights: Strong Revenue Growth and Raised ... - Yahoo Finance UK
908 Devices (NASDAQ:MASS) Director Sells $85,261.26 in Stock - MarketBeat
908 Devices (MASS) CEO Knopp sells 149K shares, reports 541K held via trust - Stock Titan
908 Devices (MASS) director Brown sells 17,800 shares in Rule 10b5-1 trades - Stock Titan
MASS Maintains Buy Rating by Stifel -- Price Target Raised to $1 - GuruFocus
908 Devices: Mission Critical Devices Drive Growth (NASDAQ:MASS) - Seeking Alpha
MASS Maintained by Roth Capital -- Price Target Raised to $13.00 - GuruFocus
908 Devices at Canaccord Genuity growth conference: growth, cash and new bets - Investing.com Canada
908 Devices at canaccord growth conference: cash, grants and new products - Investing.com Canada
Stifel raises 908 Devices stock price target on Q2 beat, guidance - Investing.com
908 Devices to Present at the 17th Annual Midwest IDEAS Investor Conference - 01net
Roth MKM Maintains 908 Devices(MASS.US) With Buy Rating, Raises Target Price to $13 - Moomoo
Stifel Maintains 908 Devices(MASS.US) With Buy Rating, Raises Target Price to $12 - Moomoo
908 Devices earnings missed by $0.17, revenue topped estimates - Investing.com Nigeria
Earnings call transcript: 908 Devices tops revenue forecast in Q2 2026 - Investing.com UK
908 Devices CEO Kevin J. Knopp disposes of USD 1.46 million in common shares - Bitget
908 Devices Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:MASS) 2026-08-11 - Seeking Alpha
908 Devices Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
908 Devices Reports Loss for Q2 2026, Misses Estimates - AlphaStreet
MASS (MASS) insider plans 140,000-share Rule 144 stock sale - Stock Titan
MASS Looks 45.1% Overvalued on GF Value™ - GuruFocus
908 Devices Releases Q2 2026 Financial Results - AlphaStreet
908 Devices Q2 2026 Earnings Call Transcript - MarketBeat
908 Devices narrows loss as revenue rises on higher product and service sales in Q2 - Minichart
908 Devices Q2 Earnings Call Highlights - MarketBeat
908 Devices Q2 2026 slides: 23% growth, profitability in sight - Investing.com
908 Devices Announces Q2 2026 Financial Results Highlighting Asset Growth and Increased Liabilities - Kalkine Media
908 Devices (NASDAQ:MASS) Announces Quarterly Earnings Results, Misses Estimates By $0.18 EPS - MarketBeat
908 디바이시스 (MASS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
908 디바이시스 주식 (MASS) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Knopp Kevin J. | President and CEO |
Aug 13 '26 |
Sale |
10.06 |
7,622 |
76,677 |
575,968 |
0.59%
0.75%
자본화:
|
볼륨(24시간):